COVID-19 - Five Years Later: Public Health officials reflect on lessons learned
Pandemic flus were on Nichole Louis’ mind. It was late 2019 and the Clinton County Health Department was in talks to work on some emergency preparedness training. “We had ended up having a roundtable ...
What we still don't know about COVID 5 years after the WHO declared a pandemic
Five years after the WHO declared COVID to be a pandemic, questions remain including how many people have died.
Long COVID could be costing U.S. between $2 billion and $6.5 billion annually
The current number of long COVID-19 cases may already be costing the U.S. $2.01–6.56 billion dollars per year, according to a ...
5 years later, long Covid is still a medical mystery: What scientists have learned
What causes long Covid? Scientists don't fully understand why some develop disabling chronic complications after recovering ...
News-Medical.Net on MSN2d
Smartwatch data provides key insights into persistent COVID symptoms
Between April 2020 and December 2022, over 535,000 people in Germany downloaded and activated the Corona Data Donation App ...
C&EN12d
Building a better COVID-19 vaccine
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
Science News12d
5 years after COVID-19 became a pandemic, are we ready for what’s next?
We’ve learned a lot about COVID-19 over the last five years, but big questions remain. Recent federal actions may hinder the disease’s management.
Healio2d
‘Early events’ can increase a person’s risk for long COVID
A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...
Smartwatch data: Study finds early health differences in long COVID patients
People who later experienced persistent shortness of breath or fatigue after a SARS-CoV-2 infection were already taking ...
Physician's Weekly3d
Repeated N-Antigen Antibody Monitoring for Assessing SARS-CoV-2 Exposure
CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...
Clinical Pain Advisor4d
Ensitrelvir Effective for COVID-19 Prevention in Exposed Household Contacts
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
Cancer Therapy Advisor11d
Does COVID-19 Cause Cancer or Help Fight It? Reviewing the Emerging Evidence
Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.